ciprofloxacin and fosfomycin

ciprofloxacin has been researched along with fosfomycin in 87 studies

Research

Studies (87)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (4.60)	18.7374
1990's	9 (10.34)	18.2507
2000's	19 (21.84)	29.6817
2010's	44 (50.57)	24.3611
2020's	11 (12.64)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Duewelhenke, N; Eysel, P; Krut, O	1
Cheung, A; Götz, F; Herbert, S; Meehl, M	1
Besier, S; Brade, V; Kahl, BC; Kraiczy, P; Wichelhaus, TA; Zander, J	1
Lombardo, F; Obach, RS; Waters, NJ	1
Herrera, ML; Jorgensen, JH; Lewis, JS; Prakash, V; Wickes, BL	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Campillo, NE; Guerra, A; Páez, JA	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Blango, MG; Mulvey, MA	1
Cars, O; Löwdin, E; Melhus, A; Tängdén, T	1
Fuller, CA; McGannon, CM; Weiss, AA	1
Auer, S; Hell, M; Wojna, A	1
Blázquez, J; Couce, A; Rodríguez-Rojas, A	1
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H	1
Barros, MT; Dias, R; Faísca Phillips, AM; Pacheco, M	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Hamilton-Miller, JM	1
Lenz, W; Machka, K; Milatovic, D; Voss, A	1
Hahn, H; Vogt, K	1
Armynot du Chatelet, AM; Attisso, MA; Maillols, M; Simeon de Buochberg, M; Zuccarelli, M	1
Attisso, MA; Dusart, G; Maillols, H; Simeon de Buochberg, M; Zuccarelli, M	1
Figueredo, VM; Neu, HC	1
Baron, D; Bugnon, D; Caillon, J; Drugeon, H; Jehl, F; Le Conte, P; Potel, G; Stephant, G; Xiong, YQ	1
Caillon, J; Drugeon, HB; Juvin, ME	1
Hoshino, E; Noda, T; Sato, T; Uematsu, H	1
Martinez-Martinez, L; Pascual, A; Perea, EJ; Rodriguez, G; Suárez, AI	1
Quentin, C; Tessier, F	1
Berkels, R; Pulverer, G; Rump, AF; Schierholz, JM; Steinhauser, H	1
Buisson, Y; Cavallo, JD; Dubrous, P	1
Acheson, DW; Keusch, GT; McDaniel, AD; Waldor, MK; Wolf, LE; Zhang, X	1
de Seze, J; Douay, X; Gauvrit, JY; Pruvo, JP; Savage, C; Stojkovic, T; Vermersch, P	1
Shaikh, N; Tarr, PI	1
Millán Rodríguez, F; Rousaud Barón, A; Rousaud Barón, F	1
Bingen, E; Bourrillon, A; Faye, A; Louzeau, C; Mariani-Kurkjian, P; Taha, MK	1
Hikida, M; Kariyama, R; Kato, Y; Kumon, H; Mikuniya, T; Monden, K	1
de Cueto, M; Hernández, JR; López-Cerero, L; Morillo, C; Pascual, A	1
Jung, DS; Ko, KS; Kwon, KT; Lee, MY; Lee, NY; Oh, WS; Peck, KR; Song, JH; Suh, JY	1
Hyo, Y; Ohmori, S; Ohuchi, M; Yamada, S	1
Ballesta, S; Pascual, A; Rodríguez-Martínez, JM	1
Bergogne-Bérézin, E	1
Blázquez, J; López, E	1
Falagas, ME; Gkegkes, ID; Kastoris, AC; Rafailidis, PI; Vouloumanou, EK	1
Adalati, R; Ceran, N; Erdem, I; Goktas, P; Kocdogan, FY; Mert, D; Ozyurek, S	1
Chakraborty, A; Gloriani, NG; Miyahara, S; Villanueva, SY; Yoshida, S	1
Barsaoui, S; Ben Jaballah, N; Bousnina, S; Bouziri, A; Hajji, N; Hariga, D; Kechrid, A; Sammoud, A; Smaoui, H	1
Armero, C; Gobernado, M; González, F; López-Quílez, A; Perpiñán, H; Sahuquillo-Arce, JM; Selva, M; Vanaclocha, H	1
Bayingana, C; Claeys, GW; Masaisa, F; Muhirwa, G; Musemakweri, A; Mutesa, L; Muvunyi, CM	1
Doki, Y; Ikeguchi, N; Mori, M; Nakajima, K; Nishida, T; Nishimura, J; Shinohara, N; Souma, Y; Takahashi, T; Takenaka, R	1
Angulo, JC; Boada, A; García-Tello, A; González-Enguita, C; Palou, J; Ramón de Fata, F; Sanz, M	1
Bleidorn, J; Gágyor, I; Hummers-Pradier, E; Schmiemann, G	1
Bachmann, A; Bonkat, G; Braissant, O; Frei, R; Gasser, TC; Müller, G; Rieken, M; Tschudin-Suter, S; Widmer, AF; Wyler, S	1
Atış, G; Canat, L; Caşkurlu, T; Güner, B; Gürbüz, C	1
Athanasiou, S; Falagas, ME; Tansarli, GS	1
Cars, O; Forsberg, P; Giske, CG; Hickman, RA; Lagerbäck, P; Tängdén, T	1
Al-Ahmad, A; Ameen, H; Anderson, AC; Hellwig, E; Karygianni, L; Pelz, K; Spitzmüller, B; Wittmer, A	1
Cheong, HJ; Cho, YK; Choi, TY; Chung, MH; Kang, JO; Ki, M; Kim, J; Kim, SJ; Kim, Y; Kwon, KT; Lee, H; Lee, JS; Lim, SK; Pai, H; Park, DW; Ryu, SY; Seo, MR; Wie, SH	1
Dörries, K; Lalk, M; Schlueter, R	1
Jiménez-Pacheco, A	1
Albesa, I; Angel Villegas, N; Baronetti, J; Becerra, MC; Etcheverría, A; Padola, NL; Paraje, MG	1
Gil-Romero, Y; Gómez-Garcés, JL; Muñoz-Paraíso, C; Regodón-Domínguez, M; Sanz-Rodríguez, N	1
Eliopoulos, GM; Hirsch, EB; Kim, Y; Kirby, JE; McCoy, C; Raux, BR; Wright, SB; Zucchi, PC	1
Almirante, B; Andreu, A; Fernández-Hidalgo, N; Larrosa, N; Los-Arcos, I; Pigrau, C; Rodríguez-Pardo, D	1
Chen, A; Eliopoulos, GM; Hirsch, EB; Kirby, JE; McCoy, C; Raux, BR; Zucchi, PC	1
Bergen, PJ; Hirsch, EB; Kirkpatrick, CM; Landersdorfer, CB; McIntosh, MP; Peleg, AY; Walsh, CC	1
Bartoletti, R; Bjerklund Johansen, TE; Cai, T; Carini, M; Cocci, A; Gacci, M; Gallelli, L; Lanciotti, M; Liguori, G; Malossini, G; Mirone, V; Naber, K; Palmieri, A; Rizzo, M; Rocco, D; Saleh, O; Tiscione, D; Trombetta, C; Vanacore, D; Verze, P; Wagenlehner, FM	1
Guneysel, O; Ozturk, TC; Suman, E	1
Gil-Romero, Y; Gómez-Garcés, JL; Merino, F; Vazquez, O	1
Arrabal-Martín, M; Arrabal-Polo, MA; Cano-García, MDC; Merino-Salas, S	1
Bauwens, A; Bielaszewska, M; Karch, H; Kunsmann, L; Mellmann, A	1
Doi, SAR; Harris, PN; Naber, K; Roberts, MJ; Scott, S; Wagenlehner, FME	1
Huotari, K; Kalalahti, I; Lahdensuo, K; Pätäri-Sampo, A; Rannikko, A; Santti, H; Tarkka, E	1
Bonten, MJM; Geerlings, SE; Hoepelman, AIM; Ten Doesschate, T; van Mens, SP; van Nieuwkoop, C	1
Cartuyvels, R; De Graeve, N; Merckx, L; Uvin, P; Van Besien, J; Van den Abeele, AM; Van Praet, C; Van Renterghem, K; Weyne, E	1
Mandal, J; Sugathan, S	1
Bekele, A; Gandhi, A; Garimella, N; Hartman, N; Li, X; Sacks, L; Stone, H; Weaver, JL; Zere, T	1
El-Wafa, WMA; Ibrahim, YM	1
Brunelli, R; Cai, T; Cipelli, R; Palagin, I; Pellini, E; Truzzi, JC; Van Bruwaene, S	1
Altun, B; Cakar, A; Demirci-Duarte, S; Eser, OK; Gur, D; Sancak, B; Unalan-Altintop, T	1
Bernal Andres, B; Gonzalez Moreno, M; Tkhilaishvili, T; Trampuz, A; Wang, L	1
Bonten, MJM; Branger, J; Geerlings, SE; Hassing, RJ; Hoepelman, AIM; Ketels, T; Koldewijn, EL; Koster, A; Kuiper, S; Ten Doesschate, T; van den Bijllaardt, W; van der Bij, AK; van Mens, SP; van Nieuwkoop, C; van Werkhoven, CH	1
Borges-Mateus, LM; Carmona-Cartaya, Y; González-Molina, MK; Hidalgo-Benito, M; Pereda-Novales, N; Quiñones-Pérez, D	1
Arendarski, P; Kramer, TS; Salm, F; Salm, J	1
Courtois, R; Danneels, P; Dubée, V; Eveillard, M; Kempf, M; Mahieu, R; Quinqueneau, C; Rihet, C; Vannier, C	1
Chung, HS; Hwang, EC; Jung, SI; Kim, MS; Kwon, DD; Ryu, JW; Yu, SH	1
Amigo, ML; Bernal, T; Blanco, LS; Boluda, B; Burgués, JMB; Calabuig, ML; Casas, MC; de Miguel, MI; de Ugarriza, PL; Del Mar García-Saiz, M; Domínguez, JF; Hernández, SC; Huerta, AJG; Humala, K; Lavín-Alconero, L; Moreno, AF; Verdugo, AF; Zarzuela, MP	1

Reviews

4 review(s) available for ciprofloxacin and fosfomycin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Lower urinary tract infections: bacterial epidemiology and recommendations]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2008, Volume: 18, Issue:1 Suppl FM Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis; Time Factors; Urinary Tract Infections	2008
Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in Africa. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8 Topics: Africa; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Databases, Factual; Drug Evaluation; Enterobacteriaceae; Enterobacteriaceae Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Prevalence; Urinary Tract Infections	2013
Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis. World journal of urology, 2018, Volume: 36, Issue:3 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Biopsy, Large-Core Needle; Ciprofloxacin; Fluoroquinolones; Fosfomycin; Humans; Image-Guided Biopsy; Levofloxacin; Male; Middle Aged; Prostate; Sepsis; Ultrasonography; Urinary Tract Infections	2018

Trials

10 trial(s) available for ciprofloxacin and fosfomycin

Article	Year
[Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany]. Deutsche medizinische Wochenschrift (1946), 1992, Dec-11, Volume: 117, Issue:50 Topics: Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Fosfomycin; Germany; Humans; Imipenem; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin	1992
[Sensitivity to fosfomycin of multiresistant serotype 012 Pseudomonas aeruginosa. Multicenter study]. Pathologie-biologie, 1997, Volume: 45, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple; Fosfomycin; In Vitro Techniques; Lactams; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Serotyping	1997
A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2010, Volume: 16, Issue:6 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Drug Administration Schedule; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; Urinary Tract Infections; Urine; Young Adult	2010
[Randomized comparative study for the assessment of a new therapeutic schedule of fosfomycin trometamol in postmenopausal women with uncomplicated lower urinary tract infection]. Actas urologicas espanolas, 2013, Volume: 37, Issue:3 Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Drug Administration Schedule; Female; Fosfomycin; Humans; Postmenopause; Prospective Studies; Single-Blind Method; Urinary Tract Infections	2013
Are prophylactic antibiotics necessary for urodynamic study? The Kaohsiung journal of medical sciences, 2013, Volume: 29, Issue:6 Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteriuria; Ciprofloxacin; Female; Fosfomycin; Humans; Male; Urodynamics	2013
Rectal E. coli above ciprofloxacin ECOFF associate with infectious complications following prostate biopsy. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Image-Guided Biopsy; Male; Microbial Sensitivity Tests; Middle Aged; Prostate; Rectum	2018
Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST). BMC infectious diseases, 2018, Dec-05, Volume: 18, Issue:1 Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Double-Blind Method; Equivalence Trials as Topic; Escherichia coli; Escherichia coli Infections; Female; Fever; Fosfomycin; Humans; Middle Aged; Placebos; Urinary Tract Infections; Young Adult	2018
Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized study. International journal of urology : official journal of the Japanese Urological Association, 2019, Volume: 26, Issue:3 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Biopsy, Large-Core Needle; Ciprofloxacin; Drug Resistance, Bacterial; Drug Substitution; Fosfomycin; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Prospective Studies; Prostate; Prostatic Neoplasms; Rectum; Treatment Outcome	2019
Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 08-25, Volume: 75, Issue:2 Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; COVID-19; Double-Blind Method; Escherichia coli; Escherichia coli Infections; Female; Fever; Fosfomycin; Humans; Urinary Tract Infections	2022
FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients-efficacy and microbiologic safety. Trials, 2023, Oct-27, Volume: 24, Issue:1 Topics: Anti-Bacterial Agents; Ciprofloxacin; Febrile Neutropenia; Fosfomycin; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute	2023

Other Studies

73 other study(ies) available for ciprofloxacin and fosfomycin

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1 Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors	2007
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8 Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance	2007
The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Proteins; Cystic Fibrosis; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Phenotype; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Thymidine	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Fosfomycin; Humans; Infusions, Parenteral; Microbial Sensitivity Tests; Outpatients; Urinary Tract Infections	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium	2010
Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Sweden; Travel; White People; Young Adult	2010
Different classes of antibiotics differentially influence shiga toxin production. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Anti-Bacterial Agents; Azithromycin; Bacteriophages; Ciprofloxacin; Escherichia coli; Escherichia coli O157; Shiga Toxin; Sulfamethoxazole; Trimethoprim	2010
Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Amdinocillin Pivoxil; Anti-Bacterial Agents; beta-Lactamases; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Urinary Tract Infections	2010
Frequency of spontaneous resistance to fosfomycin combined with different antibiotics in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Fosfomycin; Mutation; Pseudomonas aeruginosa	2010
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction	2010
Synthesis and biological evaluation of α-hydroxyalkylphosphonates as new antimicrobial agents. Bioorganic & medicinal chemistry letters, 2014, Jan-01, Volume: 24, Issue:1 Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Organophosphonates; Structure-Activity Relationship	2014
In vitro activity of fosfomycin against 'problem' gram-positive cocci. Microbios, 1992, Volume: 71, Issue:287 Topics: Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Positive Cocci; Microbial Sensitivity Tests; Rifampin	1992
Synergism between ciprofloxacin and fosfomycin against gram-negative bacteria in vitro. Zentralblatt fur Bakteriologie : international journal of medical microbiology, 1989, Volume: 272, Issue:2 Topics: Ciprofloxacin; Drug Synergism; Fosfomycin; Gram-Negative Bacteria; Humans	1989
[Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus]. Pathologie-biologie, 1988, Volume: 36, Issue:5 Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Penicillin G; Vancomycin	1988
[Post-antibiotic effect of ciprofloxacin alone and in combination on Streptococcus faecalis]. Pathologie-biologie, 1988, Volume: 36, Issue:5 Topics: Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Vancomycin	1988
Synergy of ciprofloxacin with fosfomycin in vitro against Pseudomonas isolates from patients with cystic fibrosis. The Journal of antimicrobial chemotherapy, 1988, Volume: 22, Issue:1 Topics: Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	1988
Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:2 Topics: Animals; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Fosfomycin; Pefloxacin; Pseudomonas Infections; Rabbits	1995
In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus. The Journal of antimicrobial chemotherapy, 1994, Volume: 34, Issue:6 Topics: Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin	1994
In vitro antimicrobial susceptibility to combinations of drugs on bacteria from carious and endodontic lesions of human deciduous teeth. Oral microbiology and immunology, 1993, Volume: 8, Issue:3 Topics: Amoxicillin; Bacteria, Anaerobic; Cefaclor; Child; Child, Preschool; Ciprofloxacin; Dental Caries; Dental Pulp Diseases; Drug Therapy, Combination; Fosfomycin; Humans; Metronidazole; Microbial Sensitivity Tests; Miocamycin; Tooth, Deciduous	1993
In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:6 Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin	1996
In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1997, Volume: 16, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins	1997
Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features. Biomaterials, 1997, Volume: 18, Issue:12 Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biocompatible Materials; Biofilms; Ciprofloxacin; Drug Implants; Floxacillin; Fosfomycin; Gentamicins; Humans; Materials Testing; Microscopy, Electron, Scanning; Polyurethanes; Prostheses and Implants; Prosthesis-Related Infections; Staphylococcal Infections	1997
Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. The Journal of infectious diseases, 2000, Volume: 181, Issue:2 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Ciprofloxacin; Coliphages; Disease Models, Animal; Escherichia coli Infections; Escherichia coli O157; Fosfomycin; Humans; Intestines; Male; Mice; Shiga Toxins	2000
[Paraplegia episodes revealing tuberculous myelitis]. Revue neurologique, 2000, Volume: 156, Issue:6-7 Topics: Adult; Antitubercular Agents; Ciprofloxacin; Diagnosis, Differential; Drug Therapy, Combination; Female; Fosfomycin; Humans; Magnetic Resonance Imaging; Paraplegia; Tuberculosis, Spinal	2000
Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications. Journal of bacteriology, 2003, Volume: 185, Issue:12 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteriophages; Bile Acids and Salts; Chromosome Mapping; Ciprofloxacin; Escherichia coli O157; Fosfomycin; Genome, Bacterial; Molecular Sequence Data; Recombination, Genetic; Shiga Toxin; Shiga Toxin 1; Shiga Toxin 2; Sulfamethoxazole; Trimethoprim; Virulence; Virus Integration	2003
[Pilot study of coadjuvant treatment of recurrent cystitis in women by means of AM3 (Immnoferon)]. Actas urologicas espanolas, 2003, Volume: 27, Issue:3 Topics: Adjuvants, Immunologic; Amoxicillin; Calcium Phosphates; Ciprofloxacin; Clavulanic Acid; Cystitis; Drug Evaluation; Drug Therapy, Combination; Escherichia coli Infections; Female; Follow-Up Studies; Fosfomycin; Glycopeptides; Humans; Pilot Projects; Recurrence; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vaginosis, Bacterial	2003
[Clinical aspects and outcome of meningococcal disease due to Neisseria meningitidis of serogroup W135 in 5 children]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005, Volume: 12, Issue:3 Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Female; Follow-Up Studies; Fosfomycin; Humans; Infant; Male; Meningitis, Meningococcal; Meningococcal Infections; Neisseria meningitidis; Pericarditis; Time Factors; Treatment Outcome; Uveitis	2005
Synergistic effect of fosfomycin and fluoroquinolones against Pseudomonas aeruginosa growing in a biofilm. Acta medica Okayama, 2005, Volume: 59, Issue:5 Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Drug Synergism; Fluoroquinolones; Fosfomycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Pseudomonas aeruginosa; Quinolones	2005
[Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae]. Enfermedades infecciosas y microbiologia clinica, 2006, Volume: 24, Issue:10 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Ciprofloxacin; Cross Infection; Escherichia coli; Escherichia coli Infections; Fosfomycin; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multicenter Studies as Topic; Substrate Specificity; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2006
In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood. Diagnostic microbiology and infectious disease, 2007, Volume: 58, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; Blood; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Urinary Tract Infections; Urine	2007
Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa. Chemotherapy, 2007, Volume: 53, Issue:3 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Pseudomonas aeruginosa	2007
Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin/clavulanic acid and co-trimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilms. International journal of antimicrobial agents, 2007, Volume: 30, Issue:4 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Escherichia coli; Fosfomycin; Humans; Pseudomonas aeruginosa; Trimethoprim, Sulfamethoxazole Drug Combination	2007
Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Chloramphenicol; Chromosomes, Bacterial; Ciprofloxacin; Colistin; Escherichia coli; Fosfomycin; Gentamicins; Imipenem; Microbial Sensitivity Tests; Recombination, Genetic; Rifampin; Tetracycline; Trimethoprim	2009
Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria. European journal of clinical pharmacology, 2010, Volume: 66, Issue:4 Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Bacteria; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fosfomycin; Gentamicins; Gram-Negative Bacteria; Methicillin Resistance	2010
In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Doxycycline; Erythromycin; Fluorouracil; Fosfomycin; Leptospira; Microbial Sensitivity Tests; Neomycin; Philippines; Rats; Sulfamethoxazole; Trimethoprim; Vancomycin	2010
[Iatrogenic meningitis after diagnosis lumbar puncture: 3 cases reports in the paediatric Children's Hospital of Tunis]. Bulletin de la Societe de pathologie exotique (1990), 2011, Volume: 104, Issue:1 Topics: beta-Lactam Resistance; Brain Abscess; Brain Damage, Chronic; Ciprofloxacin; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fosfomycin; Humans; Hydrocephalus; Iatrogenic Disease; Imipenem; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis, Bacterial; Muscle Hypotonia; Seizures; Serratia Infections; Serratia marcescens; Spinal Puncture; Subdural Effusion; Tunisia	2011
Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Imipenem; Infant; Male; Middle Aged; Nitrofurantoin; Retrospective Studies; Tobramycin; Young Adult	2011
Decreased susceptibility to commonly used antimicrobial agents in bacterial pathogens isolated from urinary tract infections in Rwanda: need for new antimicrobial guidelines. The American journal of tropical medicine and hygiene, 2011, Volume: 84, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Inpatients; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Outpatients; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Rwanda; Urinary Tract Infections; Young Adult	2011
The possibility of using fibrin-based collagen as an antibiotic delivery system. Surgery today, 2013, Volume: 43, Issue:2 Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aprotinin; Ciprofloxacin; Dibekacin; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Delivery Systems; Escherichia coli; Fibrinogen; Fosfomycin; Gentamicins; Mice; Mice, Inbred C57BL; Polytetrafluoroethylene; Thrombin	2013
Resistance profiles of urinary tract infections in general practice--an observational study. BMC urology, 2012, Nov-21, Volume: 12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Fosfomycin; General Practice; Germany; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Prospective Studies; Trimethoprim; Urinary Tract Infections; Young Adult	2012
Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates. World journal of urology, 2013, Volume: 31, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ciprofloxacin; Contraindications; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Male; Middle Aged; Nitrofurantoin; Prevalence; Retrospective Studies; Treatment Failure; Treatment Outcome; Urinary Tract; Urinary Tract Infections; Young Adult	2013
Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ciprofloxacin; Colistin; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fosfomycin; In Vitro Techniques; Klebsiella pneumoniae; Lipoglycopeptides; Meropenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Thienamycins; Tigecycline; Vancomycin	2014
Antibiotic resistance and capacity for biofilm formation of different bacteria isolated from endodontic infections associated with root-filled teeth. Journal of endodontics, 2014, Volume: 40, Issue:2 Topics: Actinomyces; Actinomyces viscosus; Amoxicillin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clindamycin; Dental Pulp Diseases; Doxycycline; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Fosfomycin; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Limosilactobacillus fermentum; Moxifloxacin; Penicillin G; Penicillin Resistance; Prevotella; Propionibacterium; Rifampin; Streptococcus mutans; Tetracycline Resistance; Tooth, Nonvital; Vancomycin Resistance	2014
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea. Journal of Korean medical science, 2014, Volume: 29, Issue:8 Topics: Anti-Bacterial Agents; Cefepime; Cell Survival; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Nitrofurantoin; Penicillins; Republic of Korea; Sulfadoxine; Treatment Outcome; Trimethoprim; Urinary Tract Infections	2014
Impact of antibiotics with various target sites on the metabolome of Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12 Topics: Ampicillin; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Erythromycin; Fosfomycin; Metabolic Networks and Pathways; Metabolome; Peptidoglycan; Staphylococcus aureus; Vancomycin	2014
Comment to: "Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin". Actas urologicas espanolas, 2015, Volume: 39, Issue:3 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Biopsy, Needle; Ciprofloxacin; Fosfomycin; Humans; Male; Prospective Studies; Prostate; Tromethamine	2015
Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157:H7 and non-O157 biofilms. Toxicology in vitro : an international journal published in association with BIBRA, 2015, Volume: 29, Issue:7 Topics: Animals; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Biofilms; Catalase; Cell Survival; Chlorocebus aethiops; Ciprofloxacin; Fosfomycin; Glutathione; Microbial Sensitivity Tests; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Rifamycins; Rifaximin; Shiga Toxin 1; Shiga Toxin 2; Shiga-Toxigenic Escherichia coli; Superoxide Dismutase; Vero Cells; Virulence Factors	2015
[In vitro activity of fosfomycin, alone or in combination, against clinical isolates of carbapenem resistant Pseudomonas aeruginosa]. Enfermedades infecciosas y microbiologia clinica, 2016, Volume: 34, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2016
Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates. International journal of antimicrobial agents, 2015, Volume: 46, Issue:6 Topics: Anti-Bacterial Agents; Bacteriuria; Ciprofloxacin; Cystitis; Drug Resistance, Bacterial; Enterobacteriaceae; Enterococcus; Female; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Pseudomonas aeruginosa; Urinary Bladder	2015
Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis. Antimicrobial agents and chemotherapy, 2015, Dec-14, Volume: 60, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prostatitis; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Tromethamine; Young Adult	2015
Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral Antibiotics. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:5 Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fosfomycin; Microbial Sensitivity Tests; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2016
Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:8 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Interactions; Drug Resistance, Bacterial; Fosfomycin; Humans; Microbial Viability; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2016
Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative. World journal of urology, 2017, Volume: 35, Issue:2 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Cohort Studies; Fosfomycin; Humans; Image-Guided Biopsy; Male; Postoperative Complications; Prostate; Retrospective Studies; Ultrasonography, Interventional; Urinary Tract Infections	2017
TRIMETHOPRIM-SULFAMETHOXAZOLE RESISTANCE AND FOSFOMYCIN SUSCEPTIBILITY RATES IN UNCOMPLICATED URINARY TRACT INFECTIONS: TIME TO CHANGE THE ANTIMICROBIAL PREFERENCES. Acta clinica Croatica, 2016, Volume: 55, Issue:1 Topics: Adolescent; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefpodoxime; Ceftizoxime; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult	2016
[Synergistic activity and clinical efficacy of fosfomycin and ciprofloxacin combination treatment for soft tissue infection caused by carbapenemase-producing Enterobacter cloacae]. Enfermedades infecciosas y microbiologia clinica, 2017, Volume: 35, Issue:2 Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ciprofloxacin; Colonic Diseases; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fosfomycin; Hernia, Abdominal; Herniorrhaphy; Humans; Intestinal Fistula; Minocycline; Postoperative Complications; Prosthesis-Related Infections; Soft Tissue Infections; Surgical Mesh; Tigecycline	2017
The Effect of Antibiotic Prophylaxis on Post-Operative Infection in Patients Undergone Flexible Cystos-copy. Urology journal, 2017, May-23, Volume: 14, Issue:3 Topics: Aged; Ambulatory Care; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteriuria; Ciprofloxacin; Cystoscopy; Female; Fosfomycin; Humans; Male; Middle Aged; Prospective Studies	2017
Antibiotic-Mediated Modulations of Outer Membrane Vesicles in Enterohemorrhagic Escherichia coli O104:H4 and O157:H7. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9 Topics: Anti-Bacterial Agents; Cell Membrane Structures; Ciprofloxacin; Escherichia coli Infections; Escherichia coli O104; Escherichia coli O157; Fosfomycin; Hemolytic-Uremic Syndrome; Humans; Meropenem; Microbial Sensitivity Tests; Polymyxin B; Shiga Toxin 2; Thienamycins	2017
An Journal of medical microbiology, 2019, Volume: 68, Issue:12 Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Drug Synergism; Escherichia coli; Fosfomycin; Humans; Meropenem; Microbial Sensitivity Tests; Urinary Tract Infections	2019
Effect of drug combinations on the kinetics of antibiotic resistance emergence in Escherichia coli CFT073 using an in vitro hollow-fibre infection model. International journal of antimicrobial agents, 2020, Volume: 55, Issue:4 Topics: Ampicillin; Anti-Bacterial Agents; Bioreactors; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fosfomycin; Humans; Microbial Sensitivity Tests	2020
In Vitro Activity of Fosfomycin in Double and Triple Combinations with Imipenem, Ciprofloxacin and Tobramycin Against Multidrug-Resistant Escherichia coli. Current microbiology, 2020, Volume: 77, Issue:5 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Egypt; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Tobramycin; Uropathogenic Escherichia coli	2020
Office-based approach to urinary tract infections in 50 000 patients: results from the REWIND study. International journal of antimicrobial agents, 2020, Volume: 56, Issue:1 Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Belgium; Brazil; Ciprofloxacin; Female; Fosfomycin; Guidelines as Topic; Humans; Italy; Middle Aged; Nitrofurantoin; Practice Patterns, Physicians'; Russia; Urinary Tract Infections	2020
Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant. Diagnostic microbiology and infectious disease, 2020, Volume: 98, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fosfomycin; Humans; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Urinary Tract Infections; Virulence Factors	2020
Bacteriophage-antibiotic combinations against ciprofloxacin/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model. International journal of antimicrobial agents, 2020, Volume: 56, Issue:6 Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Biofilms; Ceftriaxone; Ciprofloxacin; Combined Modality Therapy; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Fosfomycin; Gentamicins; Meropenem; Microbial Sensitivity Tests; Moths; Phage Therapy; Prosthesis-Related Infections	2020
Community-Acquired Uropathogenic MEDICC review, 2022, May-16, Volume: 24, Issue:2 Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Ciprofloxacin; Colistin; Cross-Sectional Studies; Cuba; Escherichia coli Proteins; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli	2022
High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022, Volume: 27, Issue:30 Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Laboratories; Male; Microbial Sensitivity Tests; Nitrofurantoin; Outpatients; Proteus mirabilis; Urinary Tract Infections	2022
Cefoxitin-based combination for ESBL-producing Enterobacteriaceae endocarditis. Infectious diseases now, 2022, Volume: 52, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Endocarditis; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Urinary Tract Infections	2022
Comparison of amikacin with fosfomycin as an add-on to ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy: A single-center retrospective study. Investigative and clinical urology, 2022, Volume: 63, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Ciprofloxacin; Fluoroquinolones; Fosfomycin; Humans; Male; Prostate; Retrospective Studies	2022